Deal-Making
AbbVie going big on ADCs through $10bn ImmunoGen buy
Deal MakingAbbVie going big on ADCs through $10bn ImmunoGen buyAbbVie going big on ADCs through $10bn ImmunoGen buy
The latest move in the antibody drug conjugate (ADC) space will see AbbVie add ovarian cancer drug Elahere through the purchase of ImmunoGen.